ZEISS Vision Care presented results from three clinical studies on its myopia management lenses at the recent Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, US.The studies included interim 6-month results for ZEISS MyoActive and ZEISS MyoEase, the group’s newest lenses in the category as ...

Buying a membership today will give you:
To continue reading this article register now.